Contact us
New Technology reviews with our IP Innovation Partner

Find the innovation worth backing.

ESCIRA shows advisors, investors and corporate venture teams which early-stage companies are investment ready, what their technology protects and where else it could win, and the fastest path to funding.

Pre-seed and seedSeven sectorsAnswers in two business daysBuilt for advisors and investors
7sectors covered, from AI to medical devices
2 daysfrom a company’s deck to your answer
5pages in every free Readiness Snapshot
1standard for every company, so you can compare
01 For advisors and programs

Get more of your companies funded.

Founders walk into investor meetings before they’re ready, and you hear about it after the “no.”

Know exactly what each founder needs to fix, in what order, before they walk into an investor meeting.

For: accelerators, incubators, advisory firms and economic development programs.

  • What to fix firstThe proof investors will ask for, ranked.
  • A 90-day planWork laid out week by week, with checkpoints.
  • Markets the deck missedWhere the same company could win next.
What you get
Readiness Snapshot Free
Founder Readiness Pack Two reports, plan and raise kit

Try us on one founder. Click here to submit your pitch deck and executive summary. Then we will return a Readiness Snapshot within two business days, at no cost.

Sample page: a ranked list of five things a company must prove before its round
Sample page: a ninety-day plan with two checkpoints
5 things to proveranked by what moves investors most
02 For investors

Spend your time on the right deals.

Too many decks, too little time, and technology claims that are hard to check.

A clear call on every company you send us, the questions to ask before you write a check, and which corporations would care.

For: angel groups, seed funds, family offices and corporate venture teams.

  • A clear call on every dealOne page you can read in five minutes.
  • The questions that matterWhat to ask the founder before you invest.
  • Strategic fitWho inside a large company would care, and what a pilot needs.
What you get
Investment Memo Pack Memo, card and diligence checklist
Capital-Ready Technology Diligence Add-on

Try us on one deal. Send us a company you’re weighing and we’ll return an Investment Memo plus a technology review, at no cost.

Sample page: a one-page investment summary with a recommendation and the round
Sample page: four claims a company makes about why it wins, each tested
03 For corporate innovation

Find tomorrow’s technology first.

Your next product line may already exist inside a startup you’ve never met.

Starting in 2027, corporations can become ESCIRA partners. We scout the technology areas you set, map the spaces on your roadmap, and show what a technology truly protects before you license, partner or build.

For: corporate venture, innovation, R&D and business development teams.

  • Technology ScoutingEarly-stage companies in the areas you set, with the reason each is worth a call.
  • Enterprise IntelligenceWho is building in a space, who owns what, and where to license, partner, acquire or pass.
  • Deep CRTD reportsEvery part of a technology searched, filings abroad, and the patents around it.
Partnering with ESCIRA
Technology Scouting subscription Starting in 2027
Enterprise Intelligence subscription Starting in 2027
Deep CRTD reports Quoted

Try us today. Send us one startup you’re watching and we’ll return an Investment Memo with a read on strategic fit, at no cost.

Starting in 2027Partnering for corporate teams
Technology

See the hidden value in a startup’s technology.

Many startups own more valuable technology than their pitch deck shows. Starting from a real patent search with our IP Innovation Partner, we show what it owns, where else it could win, and what it means for the raise or the deal.

Sample value map placing each part of the technology by how central and how new it is
01

What it owns

The parts of the technology that carry the value, and what protects each one.

Sample page of four markets the pitch deck never mentions
02

Where else it wins

Markets the deck never mentions, ranked and sized, with why now and who is already there.

Sample page showing the fundable range before and after the technology review
03

What it adds to the raise

How the technology changes the amount a company can raise, or the terms of a deal.

See a sample technology review
Capital-Ready Technology Diligence
Available with the Founder Readiness Pack or Investment Memo Pack. Ask about pricing
Sectors

Seven sectors. Deep where it counts.

Each sector has its own rules for winning. Every company is read against a set of questions written for its sector, and checked for the ways companies in that sector usually fail. Click a sector to see them.

Explore sectors
Offerings

Everything we offer, in one place.

Start with one company at no cost. After that, pay per company or for a team. Ask and we’ll send you pricing for your situation.

Start free
Readiness SnapshotFree

Five pages on where a company stands, for advisors. Your first one is free.

Pitch Competition KitFree

Scorecards, judge materials and a feedback report for every founder.

First page of a sample Readiness Snapshot for a fictitious company
Readiness Snapshot
First page of a sample founder feedback report from the Pitch Competition Kit
Kit feedback report
Advisors & Investors
Founder Readiness PackAsk about pricing

For advisors: two reports, a 90-day plan and a raise kit. Two business days.

Investment Memo PackAsk about pricing

For investors: memo, readiness card and diligence checklist. Two business days.

Capital-Ready Technology DiligenceAdd-on

What the technology owns, where else it can win, and what it adds to the raise. With either pack.

For teams and portfolios
Prepaid report packsAsk about pricing

Packs of 5, 10 or 25 reports, at a lower price per report.

Portfolio SummaryAsk about pricing

Up to 10 companies side by side, on one standard.

MembershipsAsk about pricing

An annual membership for adivsors and investors. Enables discounts on all offerings.

IP & Technology IntelligenceQuoted

A deeper patent search and technology review, scoped to the deal.

Coming in 2027
Market Entry BriefComing soon

How a company can win one new market.

Thesis MatchComing soon

Five matching companies a week.

Judge BriefComing soon

One page per pitch competition finalist.

ESCIRA partnerships for corporationsStarting in 2027

Technology Scouting and Enterprise Intelligence subscriptions, plus Deep CRTD reports.

AI Research AgentsStarting in 2027

• Investor Thesis Match
• ESCIRA Watch: Weekly alerts
• Readiness Sprint Tracker
• Technology Deal Flow

How it works

Three steps. Nobody logs in.

At pre-seed and seed there is little data to judge a company by. Every report adds it: claims checked against public records, a real patent search, sized markets and recent rounds like the one being raised.

  1. Send us a companyThe pitch deck and a short intake form.
  2. We do the homeworkMarket, competition, team and technology.
  3. You get the answerIn two business days, ready to act on.

How we check our calls. Every call we make goes on the record with its date, and we grade it against what actually happens.

We work with institutions. Founders come to us through the accelerator, advisor or investor working with them.

Who we are

Operators who have run companies before.

Paul Wedeking

Paul Wedeking

Founder and President

CEO at NTELX, Lusynt and Wedeking LLC. Managing Director at IBM, Principal at A.T. Kearney, Partner at AT&T Solutions and Blue Ridge Partners, SVP at DATUM.

Jason Pelletier

Jason Pelletier

Chief Executive Officer

CEO at Quantum Power Systems. Senior Director of Partnerships at Future Analytics. Director of Strategic Partnerships at KiwiTech.

Board of Advisors
Matthew Heim, PhD
Matthew Heim, PhDChief Strategy Officer, Ezassi

Thirty years running companies that sell innovation programs to large corporations: NineSigma, inno360, AMPLYFI, Clarkston Consulting and PwC.

Dan Cohrs, PhD
Dan Cohrs, PhDCFO, Emerja

A finance chief who has raised money at every scale, at D-Wave, Global Crossing and Rentech Nitrogen. Formerly taught finance at Harvard Business School.

Robert Rudelius
Robert RudeliusCEO, MedicaMetrix

Former Founder and CEO of NobleVentures. Former Partner at McKinsey & Company and Managing Partner at AT&T Solutions.

Strategic advisor: Mark McGovern, Pickwick Capital Partners  ·  Corporate counsel: Sheppard, Mullin, Richter & Hampton

Questions

Good questions, short answers.

Still curious? Talk to our team.

Who is ESCIRA for?

Advisors and programs that prepare founders, investors who back them, and corporate venture and innovation teams looking for technology. We work with institutions; founders reach us through them.

What do we get at no cost?

Your first report. Each qualified institution can send us one company. Advisors and programs get a Readiness Snapshot. Investors and corporate venture teams get an Investment Memo, plus a technology review when the company’s value rests on its technology. Corporate innovation teams get an Investment Memo with a read on strategic fit. The company must be pre-seed or seed, in one of our seven sectors, and its founders must agree to share their materials. We take a limited number each month, and we’ll ask for your feedback and, if you’re happy, permission to name you as an early user.

Can founders work with ESCIRA directly?

We work with accelerators, advisors, investors and corporations. Founders come to us through the program or investor working with them.

How fast do we get answers?

Most reports come back in two business days. Technology reviews depend on the patent search.

How do you reach your conclusions?

Every company is read against the same standard, every claim is checked, and a person reviews and signs each report. We track how our calls hold up over time.

Is a company’s information safe?

Yes. Founders agree before we start, and nothing is shared without their consent.

Do you work with corporate venture teams?

Yes. Send us one deal you’re weighing and we’ll return an Investment Memo with a read on strategic fit, plus a technology review, at no cost. Corporations choose the company; the findings stay independent.

What do the AI agents do?

They search public records each week: securities filings, patents, federal research grants, FDA records, clinical trials and funding news. Thesis Match returns companies that fit an investor’s thesis; Judge Brief prepares one page per pitch competition finalist. An ESCIRA analyst reviews everything before you receive it. The agents never contact founders and never score a company. Both are coming soon.

Do you have a referral program?

Yes. Introduce founders who need capital, or the programs and investors working with them. When they become customers, you’re rewarded. Choose “Referral partnership” in the contact form.

Is this investment or legal advice?

No. ESCIRA provides decision support. The decision stays with you.

Contact

Start with one company.

Send us one company and we’ll return your first report, at no cost. Tell us about your clients, your pipeline or the technology you’re exploring.

One no-cost first report per qualified institution. Limited each month. Reruns, updates and Deep CRTD not included.

Know founders who need capital? Introduce them through our referral program. When they become customers, you’re rewarded. Choose “Referral partnership” in the form.

About the samples on this page. Every report page shown comes from a fictitious company built to test our work. No client data appears anywhere on this site. Photos: Unsplash. ESCIRA provides educational decision support; it is not investment, legal, patent or regulatory advice.